171 related articles for article (PubMed ID: 19779967)
61. Preclinical evaluation of technetium 99m-labeled P1827DS for infection imaging and comparison with technetium 99m IL-8.
Krause S; Rennen HJ; Boerman OC; Baumann S; Cyr JE; Manchanda R; Lister-James J; Corstens FC; Dinkelborg LM
Nucl Med Biol; 2007 Nov; 34(8):925-32. PubMed ID: 17998094
[TBL] [Abstract][Full Text] [Related]
62. Clinical translation of a PSMA inhibitor for
Ferro-Flores G; Luna-Gutiérrez M; Ocampo-García B; Santos-Cuevas C; Azorín-Vega E; Jiménez-Mancilla N; Orocio-Rodríguez E; Davanzo J; García-Pérez FO
Nucl Med Biol; 2017 May; 48():36-44. PubMed ID: 28193503
[TBL] [Abstract][Full Text] [Related]
63. Diagnostic sensitivity of Tc-99m HYNIC PSMA SPECT/CT in prostate carcinoma: A comparative analysis with Ga-68 PSMA PET/CT.
Lawal IO; Ankrah AO; Mokgoro NP; Vorster M; Maes A; Sathekge MM
Prostate; 2017 Aug; 77(11):1205-1212. PubMed ID: 28649735
[TBL] [Abstract][Full Text] [Related]
64. Evaluation of 99mTc-MAG3-annexin V: influence of the chelate on in vitro and in vivo properties in mice.
Vanderheyden JL; Liu G; He J; Patel B; Tait JF; Hnatowich DJ
Nucl Med Biol; 2006 Jan; 33(1):135-44. PubMed ID: 16459269
[TBL] [Abstract][Full Text] [Related]
65. Introduction of an 8-aminooctanoic acid linker enhances uptake of 99mTc-labeled lactam bridge-cyclized α-MSH peptide in melanoma.
Guo H; Miao Y
J Nucl Med; 2014 Dec; 55(12):2057-63. PubMed ID: 25453052
[TBL] [Abstract][Full Text] [Related]
66. Plasma protein binding of (99m)Tc-labeled hydrazino nicotinamide derivatized polypeptides and peptides.
Ono M; Arano Y; Mukai T; Uehara T; Fujioka Y; Ogawa K; Namba S; Nakayama M; Saga T; Konishi J; Horiuchi K; Yokoyama A; Saji H
Nucl Med Biol; 2001 Feb; 28(2):155-64. PubMed ID: 11295426
[TBL] [Abstract][Full Text] [Related]
67. Patient-specific radiation dosimetry of 99mTc-HYNIC-Tyr3-octreotide in neuroendocrine tumors.
Grimes J; Celler A; Birkenfeld B; Shcherbinin S; Listewnik MH; Piwowarska-Bilska H; Mikolajczak R; Zorga P
J Nucl Med; 2011 Sep; 52(9):1474-81. PubMed ID: 21795364
[TBL] [Abstract][Full Text] [Related]
68. A dual-labeled Annexin A5 is not suited for SPECT imaging of brain cell death in experimental murine stroke.
Zille M; Harhausen D; De Saint-Hubert M; Michel R; Reutelingsperger CP; Dirnagl U; Wunder A
J Cereb Blood Flow Metab; 2014 Sep; 34(9):1568-70. PubMed ID: 24984896
[TBL] [Abstract][Full Text] [Related]
69. Cardioprotective effects of erythropoietin in rats subjected to ischemia-reperfusion injury: assessment of infarct size with 99mTc-annexin V.
Doue T; Ohtsuki K; Ogawa K; Ueda M; Azuma A; Saji H; Strauss HW; Matsubara H
J Nucl Med; 2008 Oct; 49(10):1694-700. PubMed ID: 18794258
[TBL] [Abstract][Full Text] [Related]
70. [99mTc]HYNIC-RGD for imaging integrin alphavbeta3 expression.
Decristoforo C; Faintuch-Linkowski B; Rey A; von Guggenberg E; Rupprich M; Hernandez-Gonzales I; Rodrigo T; Haubner R
Nucl Med Biol; 2006 Nov; 33(8):945-52. PubMed ID: 17127166
[TBL] [Abstract][Full Text] [Related]
71. XTEN-annexin A5: XTEN allows complete expression of long-circulating protein-based imaging probes as recombinant alternative to PEGylation.
Haeckel A; Appler F; Figge L; Kratz H; Lukas M; Michel R; Schnorr J; Zille M; Hamm B; Schellenberger E
J Nucl Med; 2014 Mar; 55(3):508-14. PubMed ID: 24549285
[TBL] [Abstract][Full Text] [Related]
72. Molecular imaging of MDM2 messenger RNA with 99mTc-labeled antisense oligonucleotides in experimental human breast cancer xenografts.
Fu P; Shen B; Zhao C; Tian G
J Nucl Med; 2010 Nov; 51(11):1805-12. PubMed ID: 20956468
[TBL] [Abstract][Full Text] [Related]
73. [Pharmacokinetics of 99m Tc-technephyte in radionuclide studies of the liver and spleen].
Ovdienko NI; Starovoĭtova LP; Kodina GE; Malysheva AO; Tul'skaia TI
Med Radiol (Mosk); 1987 Jul; 32(7):63-7. PubMed ID: 3613926
[TBL] [Abstract][Full Text] [Related]
74. Noninvasive Whole-Body Imaging of Phosphatidylethanolamine as a Cell Death Marker Using
Delvaeye T; Wyffels L; Deleye S; Lemeire K; Gonçalves A; Decrock E; Staelens S; Leybaert L; Vandenabeele P; Krysko DV
J Nucl Med; 2018 Jul; 59(7):1140-1145. PubMed ID: 29419481
[TBL] [Abstract][Full Text] [Related]
75. In vivo tumor angiogenesis imaging with site-specific labeled (99m)Tc-HYNIC-VEGF.
Blankenberg FG; Backer MV; Levashova Z; Patel V; Backer JM
Eur J Nucl Med Mol Imaging; 2006 Jul; 33(7):841-8. PubMed ID: 16699765
[TBL] [Abstract][Full Text] [Related]
76. 99mTc-labeled small-molecule inhibitors of prostate-specific membrane antigen: pharmacokinetics and biodistribution studies in healthy subjects and patients with metastatic prostate cancer.
Vallabhajosula S; Nikolopoulou A; Babich JW; Osborne JR; Tagawa ST; Lipai I; Solnes L; Maresca KP; Armor T; Joyal JL; Crummet R; Stubbs JB; Goldsmith SJ
J Nucl Med; 2014 Nov; 55(11):1791-8. PubMed ID: 25342385
[TBL] [Abstract][Full Text] [Related]
77. (99m)Tc human IgG radiolabelled by HYNIC. Biodistribution and scintigraphy of experimentally induced inflammatory lesions in animal model.
Karczmarczyk U; Markiewicz A; Mikołajczak R; Lisiak E; Bilski M; Pietrzykowski J; Michalik J
Nucl Med Rev Cent East Eur; 2004; 7(2):107-12. PubMed ID: 15968595
[TBL] [Abstract][Full Text] [Related]
78. (99m)Tc-annexin V and (111)In-antimyosin antibody uptake in experimental myocardial infarction in rats.
Sarda-Mantel L; Michel JB; Rouzet F; Martet G; Louedec L; Vanderheyden JL; Hervatin F; Raguin O; Vrigneaud JM; Khaw BA; Le Guludec D
Eur J Nucl Med Mol Imaging; 2006 Mar; 33(3):239-45. PubMed ID: 16283183
[TBL] [Abstract][Full Text] [Related]
79. Preliminary application of micro-SPECT/CT imaging by
Zhang Y; Meng L; Li B; Tan H; Lin QY; Cheng D; Shi H
Chem Biol Drug Des; 2019 Apr; 93(4):447-453. PubMed ID: 30381892
[TBL] [Abstract][Full Text] [Related]
80. SPECT Imaging of Treatment-Related Tumor Necrosis Using Technetium-99m-Labeled Rhein.
Liang J; Luo Q; Zhang D; Jin Q; Liu L; Liu W; Gao M; Zhang J; Yin Z
Mol Imaging Biol; 2019 Aug; 21(4):660-668. PubMed ID: 30338432
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
